LQDA vs TEVA
Liquidia Corporation vs Teva Pharmaceutical Industries Limited — AI-powered side-by-side comparison
LQDA
Liquidia Corporation
68
Buy
VS
TEVA
Teva Pharmaceutical Industries Limited
55
Watch
| Metric | LQDA | TEVA |
|---|
| AI Score |
68
|
55
|
| Price |
$88.09
|
$36.49
|
| P/E Ratio |
368.26×
|
57.19×
|
| ROE |
-154.0%
|
17.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
91.8%
|
52.5%
|
| Debt / Equity |
1.70×
|
2.16×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
55.0
|
77.8
|
| Beta |
0.572
|
0.864
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for LQDA versus TEVA.
LQDA leads by 13 points.
LQDA scores 68/100 (Buy) versus TEVA at 55/100 (Watch).
LQDA Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 46.8% shows genuine earnings power backing the valuation — Value
- Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 362.9 is expensive by classic value standards — Value
- Price-to-book of 12.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
TEVA Committee View
50% agreement
6 analysts
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.63 across 21 articles, 14d). Value Analyst remains cautious — p/e of 57.5 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 57.5 is expensive by classic value standards — Value
- Price-to-book of 4.9x prices in significant intangible value — Value
- Debt-to-equity of 2.12 adds balance-sheet risk to the value case — Value